|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 417/12 | |
| A61K 31/427 | |||
| A61P 35/00 |
| (11) | Number of the document | 3088397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16165912.3 |
| Date of filing the European patent application | 2008-04-11 | |
| (97) | Date of publication of the European application | 2016-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 911258 P | 2007-04-11 | US |
| (72) |
KAWABE, Takumi, JP
ISHIGAKI, Machiyo, JP
SATO, Takuji, JP
YAMAMOTO, Sayaka, JP
HASEGAWA, Yoko, JP
|
| (73) |
CanBas Co., Ltd.,
2-2-1, Otemachi, Numazu Shizuoka 410-0801,
JP
|
| (54) | COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER |
| COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER |